Gilteritinib (xospata ®) in turkey: early access program results

Conclusion: This research showed that patients with febrile neutropenia and peripheral edema were at a high risk of death when compared to patients without febrile neutropenia and peripheral edema.

Source: Mediterranean Journal of Hematology and Infectious Diseases - April 28, 2023 Category: Hematology Authors: Mehmet Hilmi DOGU, Ali Irfan Emre TEKGUNDUZ, Burak DEVECI, Gulten KORKMAZ, Melda COMERT, Omur Gokmen SEVINDIK, Osman YOKUS, Istemi SERIN Source Type: research